CARPENTER, RANDALL L.,ROBERTS, KATHRYN,BEAR, MARK F.
申请号:
RSP20170026
公开号:
RS55585B1
申请日:
2007.11.21
申请国别(地区):
RS
年份:
2017
代理人:
摘要:
Subjects having at least one condition selected from the group consisting of mental retardation, Downs syndrome, fragile X syndrome and autism are treated with a composition that includes gamma-am inobutyric acid agonists and/or MI muscarinic receptor antagonists. The gamma-am inobutyric acid agonist (GABA) can be a GABA(B) agonist, such as baclofen. GABA(B) agonists can be used in combination with Group I mGluR antagonists and MI muscarinic receptor antagonists in methods of treating humans.